
|Videos|December 16, 2022
Selecting Between Treatment With Cabazitaxel or Radiotherapy for Patients with mCRPC
Author(s)Neal Shore, MD, FACS
Dr Shore details how he approaches treatment selection between cabazitaxel and radiotherapy for patients with mCRPC.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
HHS requests testosterone therapy label updates, citing new safety data
2
Unmet needs and emerging solutions in MRI-guided prostate cancer care
3
Microbial dysbiosis may predict response to CBM588 in mRCC
4
Eugene Pietzak, MD, on pembrolizumab plus BCG for BCG-naïve “very high risk” T1 NMIBC
5












